Rebase Lifescience Private Limited

Rebase Lifescience Private Limited - pharma in Lalpur, Gujarat, India. FY 2026 financials & compliance.
CIN U24290GJ2019PTC106089 Incorporated 15 January 2019 ROC Ahmedabad HQ Lalpur, Gujarat, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹8.59 Cr
▲ 8% YoY
Net loss · FY 2025
₹1.28 Cr
Net margin -14.9%
EBITDA · FY 2025
₹45.29 Lakh
EBITDA margin 5.3%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹10.5 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
32
Provident fund records

About Rebase Lifescience Private Limited

Data last updated:

Rebase Lifescience Private Limited is a private limited company based in Lalpur, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2019PTC106089. Its GSTIN is 24AAJCR3607A1ZV (Gujarat).

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹10 Cr. It is led by directors including Miteshkumar Gordhanbhai Patel and Yogesh Shah.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.11 & 12 Block No.6 Nr. Amrut Dairy, Lalpur, Gujarat, India – 382430.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.59 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Cr (net margin -14.9%) and EBITDA of ₹45.29 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 182% over three years.

The company has about 32 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Rebase Lifescience. As per MCA filings, the company has open charges of ₹10.5 Cr on record. The company has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in September 2022. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Srikar Chem & Pharma India Private Limited with revenue of ₹8.6 Cr.

Rebase Lifescience Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0091684). For more details, the company can be reached via its website rebaselifescience.com.

Company details

CIN U24290GJ2019PTC106089
Registration Number 106089
Incorporation Date 15 January 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0091684

Recognitions & Rankings of Rebase Lifescience

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0091684

Contact details

Rebase Lifescience Private Limited's registered office is in Lalpur, Gujarat. Its website is rebaselifescience.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.11 & 12 Block No.6 Nr. Amrut Dairy, Lalpur, Gujarat, India – 382430
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Rebase Lifescience Private Limited, buy the company report.

Comprehensive company report
Rebase Lifescience Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Rebase Lifescience operates one associated brand: Rebase Lifescience. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing of oral dosage forms in Ahmedabad, India.rebaselifescience.com

Business activity

The main business activity of Rebase Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Rebase Lifescience Private Limited, buy the company report.

Financials of Rebase Lifescience Private Limited

FY 2024 filings available

Rebase Lifescience Private Limited reported revenue of ₹8.59 Cr (up 8% YoY) for FY 2025.

Revenue · FY 2025
₹8.59 Cr ▲ 8%
Net loss · FY 2025
₹1.28 Cr margin -14.9%
EBITDA · FY 2025
₹45.29 Lakh margin 5.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 182%
EBITDA CAGR growth
1 year
▼ 62%
3 years · compounded
▲ 44%

Revenue has grown at a compounded annual rate (CAGR) of 182% over three years, including 8% growth in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹45.29 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.28 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.3%
Net Profit Margin-14.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rebase Lifescience Private Limited, buy the company report.

Board of directors of Rebase Lifescience Private Limited

Rebase Lifescience has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Miteshkumar Gordhanbhai PatelDirector15 Jan 20197 Years 10 MonthsCurrent
Yogesh ShahDirector31 May 20242 Years 5 MonthsCurrent
Minesh Manharlal SutharDirector24 Dec 20205 Years 10 MonthsCurrent

Peer comparison

Rebase Lifescience Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Srikar Chem & Pharma India Private Limited₹8.6 Cr (FY 2024)-11.0%Hyderabad, Telangana, India
Zahidi Pharmaceuticals Private Limited₹8.6 Cr (FY 2025)2.0%Umbergaon, Gujarat, India
Kaizen Research Labs India Private Limited₹8.6 Cr (FY 2025)-17.0%Chennai, Tamil Nadu, India
Rebase Lifescience Private Limitedthis company₹8.59 Cr (FY 2025)-₹1.28 Cr-14.9%8.0%32Lalpur, Gujarat, India
Qpharm Health Care Limited₹8.59 Cr (FY 2024)40.0%Jaipur, Rajasthan, India
Rexcin Pharmaceuticals Private Limited₹8.57 Cr (FY 2025)15.0%New Delhi, Delhi, India
Lutim Pharma Private Limited₹8.57 Cr (FY 2024)6.0%Dehradun, Uttarakhand, India

To see the full peer comparison of Rebase Lifescience Private Limited, buy the company report.

Auditor

Rebase Lifescience Private Limited is audited by B S Pandya & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
B S Pandya & AssociatesFY 2024142825W

Shareholding

The shareholding of Rebase Lifescience Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rebase Lifescience Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10.5 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹10.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Jan 2021100415278State Bank of India₹5.25 CrOpen
22 Jan 2021100415286State Bank of India₹5.25 CrOpen

Total charge records: 2 View all charges

Deals & funding

Rebase Lifescience Private Limited has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in September 2022.

Total deals
4
Rights issues
2
Secondary share transfers
2

Deals on record (4 of 4)

WhenDealAmountParties
Sep 2022Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2021Rights issue₹4.14 CrInvestors: 4 individuals
Seller: an individual
Mar 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Apr 2019Rights issue₹1.49 CrInvestors: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rebase Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Rebase Lifescience Private Limited has a workforce of 32 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
32
Active EPFO establishments
1
Employee growth
-25.6%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2732
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22

To see the full employee and EPFO history of Rebase Lifescience Private Limited, buy the company report.

GST

Rebase Lifescience has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAJCR3607A1ZVGujaratActive04 Feb 2019

To see the full GST registrations and return filing status of Rebase Lifescience Private Limited, buy the company report.

Recent activity

Rebase Lifescience Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Yogesh Shah ceased to be Additional Director on 29 Sep 2024.

AGM
Rebase Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Yogesh Shah ceased to be Additional Director.
Appointed
Yogesh Shah was appointed as Director.
Filing
Rebase Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Minesh Manharlal Suthar ceased to be Additional Director.
Charges
A charge with State Bank Of India amounted to Rs. 5.25 Cr with Charge ID 100415278 was registered on 25 Jan 2021.
Charges
A charge with State Bank Of India amounted to Rs. 5.25 Cr with Charge ID 100415286 was registered on 22 Jan 2021.
Appointed
Minesh Manharlal Suthar was appointed as Director.
Ceased
Shailesh M Patel ceased to be Additional Director.
Ceased
Shitalben Rajendra Kumar Jadvani ceased to be Director.
Appointed
Miteshkumar Gordhanbhai Patel was appointed as Director.
Incorporation
15 Jan 2019
Rebase Lifescience Private Limited was registered on 15 Jan 2019 with Roc Ahmedabad & aged 7 years 10 months as per MCA records.

Frequently asked questions

Rebase Lifescience is an active private limited company based in Lalpur, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 2019 (7+ years old) and is registered under CIN U24290GJ2019PTC106089.

Rebase Lifescience has 3 current directors:

The latest financial statements of Rebase Lifescience on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Rebase Lifescience is 24AAJCR3607A1ZV, registered in Gujarat.

The CIN (Corporate Identification Number) of Rebase Lifescience is U24290GJ2019PTC106089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rebase Lifescience was incorporated on 15 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Rebase Lifescience has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in September 2022.

The peers of Rebase Lifescience by revenue are Srikar Chem & Pharma India Private Limited, Zahidi Pharmaceuticals Private Limited, Kaizen Research Labs India Private Limited, Qpharm Health Care Limited, Rexcin Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Yogesh Shah ceased to be Additional Director on 29 Sep 2024. Yogesh Shah was appointed as Director on 31 May 2024. Minesh Manharlal Suthar ceased to be Additional Director on 15 Oct 2021. Rebase Lifescience has 7 board changes on record in total.

Yes, Rebase Lifescience is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0091684).

Rebase Lifescience can be reached through the website rebaselifescience.com. Its registered office is in Lalpur, Gujarat, India.